189 related articles for article (PubMed ID: 28779156)
1. Dysfunctional high-density lipoproteins have distinct composition, diminished anti-inflammatory potential and discriminate acute coronary syndrome from stable coronary artery disease patients.
Carnuta MG; Stancu CS; Toma L; Sanda GM; Niculescu LS; Deleanu M; Popescu AC; Popescu MR; Vlad A; Dimulescu DR; Simionescu M; Sima AV
Sci Rep; 2017 Aug; 7(1):7295. PubMed ID: 28779156
[TBL] [Abstract][Full Text] [Related]
2. Clusterin, paraoxonase 1, and myeloperoxidase alterations induce high-density lipoproteins dysfunction and contribute to peripheral artery disease; aggravation by type 2 diabetes mellitus.
Sanda GM; Toma L; Barbalata T; Moraru OE; Niculescu LS; Sima AV; Stancu CS
Biofactors; 2022 Mar; 48(2):454-468. PubMed ID: 34741558
[TBL] [Abstract][Full Text] [Related]
3. Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease.
Kimak E; Zięba B; Duma D; Solski J
Lipids Health Dis; 2018 Apr; 17(1):71. PubMed ID: 29618370
[TBL] [Abstract][Full Text] [Related]
4. Acute coronary syndrome remodels the protein cargo and functions of high-density lipoprotein subfractions.
Tan Y; Liu TR; Hu SW; Tian D; Li C; Zhong JK; Sun HG; Luo TT; Lai WY; Guo ZG
PLoS One; 2014; 9(4):e94264. PubMed ID: 24736723
[TBL] [Abstract][Full Text] [Related]
5. Apolipoproteins as the basis for heterogeneity in high-density lipoprotein2 and high-density lipoprotein3. Studies by isoelectric focusing on agarose films.
Marcel YL; Weech PK; Nguyen TD; Milne RW; McConathy WJ
Eur J Biochem; 1984 Sep; 143(3):467-76. PubMed ID: 6479161
[TBL] [Abstract][Full Text] [Related]
6. Hyperglycemia Determines Increased Specific MicroRNAs Levels in Sera and HDL of Acute Coronary Syndrome Patients and Stimulates MicroRNAs Production in Human Macrophages.
Simionescu N; Niculescu LS; Carnuta MG; Sanda GM; Stancu CS; Popescu AC; Popescu MR; Vlad A; Dimulescu DR; Simionescu M; Sima AV
PLoS One; 2016; 11(8):e0161201. PubMed ID: 27519051
[TBL] [Abstract][Full Text] [Related]
7. Acute coronary syndrome remodels the antiplatelet aggregation properties of HDL particle subclasses.
Garcia C; Montée N; Faccini J; Series J; Meilhac O; Cantero AV; Le Faouder P; Elbaz M; Payrastre B; Vindis C
J Thromb Haemost; 2018 May; 16(5):933-945. PubMed ID: 29543379
[TBL] [Abstract][Full Text] [Related]
8. [Age related decrease of high density lipoproteins (HDL) in women after menopause. Quantification of HDL with genetically determined HDL arylesterase in women with healthy coronary vessels and in women with angiographically verified coronary heart disease].
Chemnitius JM; Winkel H; Meyer I; Schirrmacher K; Armstrong VW; Kreuzer H; Zech R
Med Klin (Munich); 1998 Mar; 93(3):137-45. PubMed ID: 9564161
[TBL] [Abstract][Full Text] [Related]
9. Association between HDL particles size and myeloperoxidase/ paraoxonase-1 (MPO/PON1) ratio in patients with acute coronary syndrome.
Emami Razavi A; Basati G; Varshosaz J; Abdi S
Acta Med Iran; 2013 Jul; 51(6):365-71. PubMed ID: 23852840
[TBL] [Abstract][Full Text] [Related]
10. HDL Phospholipids, but Not Cholesterol Distinguish Acute Coronary Syndrome From Stable Coronary Artery Disease.
Meikle PJ; Formosa MF; Mellett NA; Jayawardana KS; Giles C; Bertovic DA; Jennings GL; Childs W; Reddy M; Carey AL; Baradi A; Nanayakkara S; Wilson AM; Duffy SJ; Kingwell BA
J Am Heart Assoc; 2019 Jun; 8(11):e011792. PubMed ID: 31131674
[TBL] [Abstract][Full Text] [Related]
11. MiR-486 and miR-92a Identified in Circulating HDL Discriminate between Stable and Vulnerable Coronary Artery Disease Patients.
Niculescu LS; Simionescu N; Sanda GM; Carnuta MG; Stancu CS; Popescu AC; Popescu MR; Vlad A; Dimulescu DR; Simionescu M; Sima AV
PLoS One; 2015; 10(10):e0140958. PubMed ID: 26485305
[TBL] [Abstract][Full Text] [Related]
12. Plasmalogens of high-density lipoproteins (HDL) are associated with coronary artery disease and anti-apoptotic activity of HDL.
Sutter I; Velagapudi S; Othman A; Riwanto M; Manz J; Rohrer L; Rentsch K; Hornemann T; Landmesser U; von Eckardstein A
Atherosclerosis; 2015 Aug; 241(2):539-46. PubMed ID: 26093887
[TBL] [Abstract][Full Text] [Related]
13. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.
Haraguchi Y; Toh R; Hasokawa M; Nakajima H; Honjo T; Otsui K; Mori K; Miyamoto-Sasaki M; Shinohara M; Nishimura K; Ishida T; Hirata K
Atherosclerosis; 2014 Jun; 234(2):288-94. PubMed ID: 24704632
[TBL] [Abstract][Full Text] [Related]
14. Administration of eicosapentaenoic acid may alter high-density lipoprotein heterogeneity in statin-treated patients with stable coronary artery disease: A 6-month randomized trial.
Tani S; Matsuo R; Yagi T; Matsumoto N
J Cardiol; 2020 Mar; 75(3):282-288. PubMed ID: 31543378
[TBL] [Abstract][Full Text] [Related]
15. Lutein exerts anti-inflammatory effects in patients with coronary artery disease.
Chung RWS; Leanderson P; Lundberg AK; Jonasson L
Atherosclerosis; 2017 Jul; 262():87-93. PubMed ID: 28527371
[TBL] [Abstract][Full Text] [Related]
16. [The utility of high density lipoprotein cholesterol subclasses measurement].
Skoczyńska A; Turczyn B; Kuliszkiewicz-Janus M; Derkacz A; Poreba R
Pol Arch Med Wewn; 2002 Jun; 107(6):525-32. PubMed ID: 12371385
[TBL] [Abstract][Full Text] [Related]
17. Defects of High-Density Lipoproteins in Coronary Artery Disease Caused by Low Sphingosine-1-Phosphate Content: Correction by Sphingosine-1-Phosphate-Loading.
Sattler K; Gräler M; Keul P; Weske S; Reimann CM; Jindrová H; Kleinbongard P; Sabbadini R; Bröcker-Preuss M; Erbel R; Heusch G; Levkau B
J Am Coll Cardiol; 2015 Sep; 66(13):1470-85. PubMed ID: 26403344
[TBL] [Abstract][Full Text] [Related]
18. The value and distribution of high-density lipoprotein subclass in patients with acute coronary syndrome.
Tian L; Li C; Liu Y; Chen Y; Fu M
PLoS One; 2014; 9(1):e85114. PubMed ID: 24465490
[TBL] [Abstract][Full Text] [Related]
19. Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level.
Paavola T; Kuusisto S; Jauhiainen M; Kakko S; Kangas-Kontio T; Metso J; Soininen P; Ala-Korpela M; Bloigu R; Hannuksela ML; Savolainen MJ; Salonurmi T
PLoS One; 2017; 12(2):e0171993. PubMed ID: 28207870
[TBL] [Abstract][Full Text] [Related]
20. Featured Article: Depletion of HDL
Soupene E; Larkin SK; Kuypers FA
Exp Biol Med (Maywood); 2017 Jun; 242(12):1244-1253. PubMed ID: 28436274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
